Praxis Program Nets $1.8M Savings
Praxis, the Brentwood, TN-based centralized patient recruitment and retention company, announced the status of a current recruitment and retention program for a top pharmaceutical company currently studying a mental health issue in Phase III.
Praxis is providing services for two studies in Phase III, for which it had successfully completed a prior Phase III recruitment initiative. While the trials seek different patient populations, they are complimentary. Because of this, Praxis was able to develop an umbrella program for the sponsor under which both protocols can be effectively and simulatneously recruited. Based on the umbrella program, the sponsor was able to save $1.8 million in clinical program costs.
Praxis used both past experience in mental health studies, with the predictive modleing of its PraxisDirect 2.0 software to design the program to meet enrollment goals. Nearly 2,000 patients will be randomized across 75 sites within a nine-month period. Praxis has experience with mental health areas including bipolar depression, major depressive disorder (MDD), and bipolar mania.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
